816-817 / 2351
NPC 9902 TRIAL Hong Kong
‐
–
•
4 arm trial
•
T3‐4 N0‐1
•
N=189 (planned 464)
•
>66 Gy at 2 Gy per fraction
–
Five vs. six fractions/week
•
Chemotherapy
–
±concurrent cisplatin plus adjuvant cisplatin and
5‐fluorouracil (Intergroup 0099 regimen)
Lee A, Int. J. Radiation Oncology Biol. Phys., Vol. 66, No. 1, pp. 142–151, 2006